Speculating, a similar process in PD-L1 expressing cells could cause reduced cellular lipid uptake upon anti-PD-L1 therapy, thus elevating free fatty acid levels at the plaque site, possibly worsening atherosclerosis. This evidence concerns the gene CD274 and atherosclerosis.